Fritextsökning
Innehållstyper
-
Clinical trials in large scale to Stockholm
Karolinska Trial Alliance, KTA, will open a medical clinical for clinical trials in Phases II-IV. The clinic will be able to accommodate up to 150 patients per ...
-
Trio goes in for high tech medicines
The Swedish drug discovery company Beactica announces fragment-based drug discovery research collaboration with GE Healthcare and the University of Uppsala.
-
Hon tar över EU-support
Tuulikki Lindmark är ny på posten.
-
Respiratorius hunts millions
The biopharmaceutical company Respiratorius has got a new CEO, who starts a public new share issue to catch almost SEK ten million.
-
Testar kapslar mot Alzheimer
En ny klinisk studie visar lovande effekter av kapslar som frisätter tillväxtfaktorn NGF.
-
De får högst forskningsbidrag av Vetenskapsrådet
Jan Nilsson, Leif Groop och Jonas Frisén ska driva de projekt som fick högst bidrag i årets bidragsutdelning inom medicin och hälsa.
-
New partnering platform
EBD Group's Partnering One is the new partnering platform for Biotech Forum 2009.
-
Platform for high security virus purification
Millipore Corporation has introduced the Viresolve Pro Solution system, a new system for purification of viruses. The technology in the new platform includes a ...
-
New firm based on SLU research
Four researchers at the Swedish University of Agricultural Sciences, SLU, has recently founded a new nanotech company.
-
Norwegian cancer therapy leaves phase II
New clinical results from Algeta highlights the potential of Alpharadin to treat bone metastases in major cancer indications.
-
Presenterar data från två kliniska studier
Sobi och partnern Biogen visar upp nya resultat på kongress i Kanada.
-
Ny vd på Diagenic
Plockar chef från oljeindustrin.
-
Test if you carry the fat virus
In a soon future there may be a quick and simple test that could show if you are infected with Ad-36, a human adenovirus that can make you over-weight.
-
24 tävlar om entreprenörspris
Fem life science-bolag är med och tävlar i entreprenörstävlingen The Serendipity Challenge nästa vecka.
-
Orexo opens doors eastwards
The drug delivery company has signed a deal for selling a cancer pain treatment in China. "An ideal partner for us" says Torbjörn Bjerke, CEO of Orexo.
-
Hoppas på Brilinta
Astrazeneca hoppas på ökad försäljning efter positiva resultat från en klinisk studie.
-
Annika Garnås, LAB
Why are you going to Scanlab+Biotech Forum?
-
Nya läkemedel ökar i USA
Under 2012 godkände FDA rekordmånga nya medicinska behandlingar. Bland annat godkändes Johnson and Johnsons Sirturo, som är den första nya TBC-behandlingen på många år.
-
Symphogen buys tumor blocking technology
The seller is a pioneer in developing ligand traps to treat cancer and other diseases. "An excellent fit with our scientific and strategic focus," said Kirsten ...
-
Mathematician new dean at DTU
On January 1st the Technical University of Denmark, DTU, got a new dean, recruited from the department of Mathematics.
-
Oslo Cancer Cluster
Cancer is, of course, the focus for this Oslo-based cluster, which is solely dedicated to cancer treatment and diagnostics. Oslo cancer cluster is also a part o...
-
Danisco strengthens its IP team
Danisco's division Genencor has appointed a new Vice President of Intellectual Property Strategy and Chief IP Counsel.
-
75 million for research schools
Gothenburg University, Karolinska Institutet, Linköping University and Umeå University have received SEK 75 million from the Research Council. The money will be used to build five national clinical research schools. The research schools will receive 15...
-
Pledpharma fortsätter fas II-studie
Får klartecken att sätta igång del två i studieprogrammet Pliant.
BREAKING